Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John G. Cooper Insider Profile
4 Followers
John G. Cooper, President & CEO, Director at Windtree Therapeutics, holds 95.45K shares in Rockwell Med (Ticker: RMTI), holds 111.82K shares in Windtree Therapeutics (Ticker: WINT).
John G. Cooper has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John G. Cooper holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John G. Cooper
John G. Cooper's Trading History
Windtree Therapeutics
Jul 24, 2015
President & CEO, Director
Uninformative Buy
―
$57.03K
Rockwell Med
May 23, 2024
Director
Uninformative Buy
―
$222.40K
List of latest transactions for each holding click on a transaction to see John G. Cooper's performance on stock
You May Also Like
John G. Cooper insider profile FAQ
What is the percentage of profitable transactions made by John G. Cooper?
The percentage of profitable transactions made by John G. Cooper is ―.
What is the average return per transaction made by John G. Cooper?
The average return per transaction made by John G. Cooper is ―.
What stocks does John G. Cooper hold?
John G. Cooper holds: WINT, RMTI stocks.
What was John G. Cooper’s latest transaction?
John G. Cooper latest transaction was an Uninformative Buy of ―.
What was John G. Cooper's most profitable transaction?
John G. Cooper’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John G. Cooper's role in Windtree Therapeutics?
John G. Cooper's role in Windtree Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.